Case Study Of Wuxi Apptec's IPO Return To A Shares

For a long time,due to the harsh conditions and strict auditing in the domestic market,some companies with good growth do not meet the conditions of domestic listing,and they have chosen to go overseas for listing.These enterprises are called Chinese stock companies.Since the listing of Chinese stock companies,the development process can be described by ups and downs.From the beginning,not to be optimistic about the market,to the rapid development and rise of the later,and finally faced with difficulties and the emergence of the stock market crisis,resulting in the delisting and privatization wave of the Chinese stocks.However,the road to the return of the Chinese stock market is not smooth,but accompanied by various obstacles and difficulties.In the stock market,we want to return.We can only rely on privatization channels.Backdoor returns require the support of a large amount of funds.The IPO returns to a long queue and has high audit thresholds,and it is not a general enterprise that can afford energy.WuXi PharmaTech,as the first Chinese stock company to return to A-shares through IPO,provides an analysis and reference for other Chinese stock companies by analyzing the innovations and motivations of its regression path.The paper consists of five parts.The introduction is the first part,introducing the significance and background of the research,and then combs the literature on the return of stocks at home and abroad.It also introduces the research content and research methods of this paper.The second part is about the middle.The relevant theory of stock return mainly starts from the concept of stocks,the model of return and the theory of the basis of the stocks return.The next part is the case of the return of WuXi PharmaTech,including the case background of WuXi PharmaTech,the company profile.And the motivation analysis of regression;the fourth part is the case analysis of WuXi PharmaTech's return to A-share,which mainly includes the following contents: the analysis of the regression process of WuXi PharmaTech,the selection of regression model and the effect analysis of IPO regression A-share,effect analysis Partly,it is measured by indicators such as financial status,market performance,shareholding structure,and company size.The fifth part is based on the analysis and discussion in the previous chapters.Finally,it is concluded that the return of WuXi PharmaTech is a success.Cases,the financial status of the company has been improved,and the research implications are for the Chinese stocks and for the regulatory authorities.Both stand on a different point of view,and then gives research revelation.The study found that WuXi PharmaTech's main business “one-three” and IPO return to A-shares have improved the financial status of the company,improved financial performance,increased shareholder wealth,and the equity structure is more concentrated than before,which is conducive to production and operation decisions.The size of the company has also expanded a lot before the listing.In general,WuXi PharmaTech's return is very successful.Therefore,in view of the conclusions of the case analysis,this paper proposes the following revelations: the Chinese stocks should correct the return motivation;the Chinese stocks should choose the appropriate regression model;the supervisory layer should steadily and steadily advance the approval system to the registration system reform;Capital market system;promote the diversification of the return path of the stocks.The topic based on this article is an open hotspot,and many financial data may not be obtained enough.It may not be so strong in persuasiveness.There are many shortcomings.I will continue to improve in the future study.More information and data can be obtained for more comprehensive and accurate research and analysis.